The Council of Scientific and Industrial Research (CSIR), working in line on its vision of safeguarding the nation’s health, highlighted ‘Generics & Healthcare’ as its time during CSIR Platinum Jubilee Technofest at 36th India International Trade Fair, Pragati Maidan. It got together a wide range of innovations, technologies and products displayed in the pavilion and got together distinguished scientists, researchers and industrial partners of CSIR to brainstorm at various the seminar organised on this theme day. Scientists from CSIR-IMTECH, CSIR-NBRI, CSIR-NCL, CSIR-IIIM, CSIR-CCMB, CSIR-CFTRI, CSIR-IHBT and CSIR-CSMCRI also contributed significantly at the seminar on the 12thday of CSIR Platinum Jubilee Technofest.
To highlights some of CSIR’s distinct collaborative achievements, CSIR-CDRI, Lucknow has developed the world’s first Oral Contraceptive Centchroman Pills, ‘Saheli’ for women, which has benefitted more than 6 lakhs women p.a.. Its effective in preventing heavy menstrual bleeding, abnormal bleeding and nostalgia, it also acts as anti-cancer against breast, head, neck, and chronic myeloid leukemia cells.
Addressing the seminar, Dr. Arun Bandopadhyay, CSIR-IICB said, “CSIR-IICB has innovated drugs and technologies to fight chronic heart diseases. The Rheumatic Heart Disease (RHD), a very common disease in rural areas, is hampering the health of the nation. It appears in early child days as fever, and then it leading valve disorder if not detected early. People die without proper diagnosis.”
Dr R. Ramaiah, Director, CSIR-NEIST, Jorhat said, “Efficacy of drugs is very important in herbal products. ‘Good labs practices’ must be attained by the developers of drugs. We have developed anti-arthritis drug over the years just to get assured on the safety of the drugs. Now we have licensed it for commercial launch.”
Prof. Samit Chattopadhyay, Director, CSIR-IICB said, “We have developed anti-cancer drugs. Some more drugs like Prostalyn already in the market cure enlarged prostate which causes cancer. Leishmania Diagnostic Kit will be launched soon to heal Kala Azar.”
Dr. B. Narsaiah, Scientist, CSIR-IICT stated that anti-cancer drugs are now easily available. The institute has come up with Anti Tuberculosis drugs. Our aim is to develop economically viable technologies for drugs.
The seminar was later addressed by Dr. Srinivas from pharmaceutical giant, Cipla on the ‘generics scenario’. He said, “India spends a lot of money in the research in generics. There is a huge potential in developing more generics drugs with the collaboration of institutions like CSIR. It has multiple set-ups under one roof.”